So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.

People are living longer, living better with multiple myeloma. But I think for the vast majority of people who are diagnosed, we still don't have a curative treatment for multiple myeloma, so that, to ...

Pomalyst belongs to a group of drugs called immunomodulators. Pomalyst is also used to treat other conditions, but this article focuses on its use for treating multiple myeloma. To learn more ...

The following is a summary of “Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma, ...

The Connect MM Registry is the longest-running and largest registry in the US, providing invaluable prognostic insights into ...

The panelist discusses how for managing patients with R/R multiple myeloma, community clinicians should focus on personalized ...

Panelists discuss how to navigate and choose among multiple guideline-recommended induction regimens for patients with ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

and Kyprolis is prescribed only after you’ve received other multiple myeloma treatments. Your doctor will likely recommend that you do not receive live vaccines during your Kyprolis treatment.

Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new ...

In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, talks unmet need in ...